How well has GSK assessed the risks of their product development and sales with respect to their ability to maximize shareholder value?
You have been commissioned to produce a report on Glaxo Smith Kline. The key question at hand is:
‘How well has GSK assessed the risks of their product development and sales with respect to their ability to maximize shareholder value?’
Your report should consider:
The context of the pharmaceutical industry.
The ‘blockbuster’ business model.
GSK’s strategies for meeting the challenges of a changing industry context
Company, media and analyst narratives.
‘Hard’ data such as year on year sales growth, market share and share price.
Scholarly perspectives on pharma and GSK, as appropriate.
How risks are assessed over the patent life of a drug
7 Pages maximum length – excluding bibliography (i.e. biblio’ does not count)
GSK report information and the case pack has all the very useful info about this research paper.
All the files attached are relevant and should be used when writing this paper, there are several excel spreadsheets with relevant info, many readings etc.
There are three example essays attached for your reference.
All the relevant lectures and seminars are also attached for your reference.
